Literature DB >> 7864137

Human SP-A: then and now.

J Floros1, A M Karinch.   

Abstract

In the short span of ten years, our understanding of human surfactant-associated protein A (SP-A) has advanced rapidly at both the level of the protein and the level of the gene. In the period 1984-1988, the protein was biochemically characterized and two SP-A precursors were identified. The molecular characterization was begun with the publication of an SP-A genomic sequence and sequences of two SP-A cDNAs, suggesting the presence of two SP-A genes. In the period 1991-1992, an SP-A pseudogene, a second SP-A genomic sequence, and an SP-A allelic variant were described. Since that time, a picture of increasing complexity has emerged from studies of the two SP-A genes. This complexity includes alternative splicing of 5' untranslated exons, allelic variants of both SP-A genes, and sequence heterogeneity within the 3' untranslated region. The challenge for the future will be to discover the physiological significance of the genetic complexity of human SP-A.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864137     DOI: 10.1152/ajplung.1995.268.2.L162

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

Review 1.  Surfactant protein-A: new insights into an old protein--II.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

2.  Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans.

Authors:  A M Karinch; D E deMello; J Floros
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

3.  Translation in vivo of 5' untranslated-region splice variants of human surfactant protein-A.

Authors:  A M Karinch; J Floros
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

4.  On the significance of Surfactant Protein-A within the human lungs.

Authors:  Torsten Goldmann; Daniel Kähler; Holger Schultz; Mahdi Abdullah; Dagmar S Lang; Florian Stellmacher; Ekkehard Vollmer
Journal:  Diagn Pathol       Date:  2009-03-12       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.